MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro

Brain Research

Volumn 920, Issue 1-2, 2001, Pages 202-209

  Biello, Stephany M ^a   Dafters, Richard I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

MDMA, 3,4 methylenedioxymethamphetamine; PRC, phase response curve; SCN, suprachiasmatic nuclei; ZT, Zeitgeber time

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; FENFLURAMINE; SEROTONIN 1A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ELECTROPHYSIOLOGY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP DISORDER; SUPRACHIASMATIC NUCLEUS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CIRCADIAN RHYTHM; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; FENFLURAMINE; HALLUCINOGENS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0035976631     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03070-0     Document Type: Article

References (39)

1. Circadian rhythmicity in the GABAergic system in the suprachiasmatic nuclei of the rat
2. Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine(1A) receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: The role of corticosteroids
3. MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: Blockade by drugs preventing 5-hydroxytryptamine depletion
4. Persistent effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') on human sleep
5. MDMA-induced neurotoxicity - Parameters of degeneration and recovery of brain-serotonin neurons
6. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): Assessment using quantitative autoradiography
7. Depletion of brain-serotonin differently affects behaviors induced by 5-HT1a, 5-HT1c, and 5-HT2 receptor activation in rats
8. Circadian phase shifts to neuropeptide Y in vitro: Cellular communication and signal transduction
9. Long-term serotonin reinnervation of the suprachiasmatic nucleus after 5,7-dihydroxytryptamine axotomy in the adult rat
10. Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy') but not by fenfluramine
11. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy') in humans correlates with EEG power and coherence
12. Circadian rhythms and the pharmacology of affective illness
13. The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A, C receptor agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)
14. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy)
15. Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: A potential daytime regulator of the biological clock
16. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('Ecstasy')
17. Species differences between hamsters and rats with regard to the putative role of serotonin in the circadian system
18. Circadian rhythms, athletic performance, and jet lag
19. Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) - A controlled study in humans
20. Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings
21. GABA is the principal neurotransmitter of the circadian system
22. Lasting psychological sequelae of recreational use of MDMA ('Ecstasy'): Controlled studies in humans
23. Memory deficits associated with recreational use of 'Ecstasy'
24. Serotonin and the regulation of mammalian circadian rhythmicity
25. Phase response curves for social entrainment
26. Psychobiological problems in heavy 'ecstasy' (MDMA) and polydrug users
27. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists
28. Serotonergic actions and interactions on the SCN circadian pacemaker: In vitro investigations
29. Ecstasy-fueled 'Rave' parties become dances of death for English youths
30. Serotonergic modulation of photic entrainment in the Syrian hamster
31. 3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in non-human primates
32. Circadian rhythm sleep disorders: Pathophysiology and treatment
33. Neural regulation of circadian rhythms
34. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors
35. MDMA ('Ecstasy') consumption in the context of polydrug abuse: A report on 150 patients
36. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
37. Neurotoxicity of MDMA: Neurochemical effects
38. Extent of colocalization of serotonin and GABA in the neurons of the rat raphe nuclei
39. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons